Funding for this research was provided by:
Leukemia and Lymphoma Society (6602-20)
Received: 17 November 2019
Accepted: 24 February 2020
First Online: 6 August 2020
Ethics Approval and Consent to participate
: This study was approved by the Institutional Review Board of the University of Arkansas for Medical Sciences under protocol number 260284.
: Not applicable
: The authors declare they have no competing interests.